Kavita Singh
Overview
Explore the profile of Kavita Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
339
Citations
4154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Mesa J, Arango-Ibanez J, Perel P, Prabhakaran D, Leon-Giraldo H, Toro-Pedroza A, et al.
Glob Heart
. 2025 Mar;
20(1):21.
PMID: 40026348
Background: COVID-19 has led to nearly seven million deaths and male sex has been reported as one of the main risk factors for mortality. Few studies have analyzed cohorts of...
2.
Ruchitha S, Gupta N, Singh K
Arch Dermatol Res
. 2025 Feb;
317(1):499.
PMID: 40009222
This review addresses gaps in understanding isotretinoin's side effects for acne vulgaris. While effective, the risks are often underestimated. It emphasizes careful patient selection and monitoring to optimize outcomes and...
3.
Yadav Y, Singh K, Tyagi R, Sagar R
Org Biomol Chem
. 2025 Feb;
PMID: 39989371
Herein, we report a highly efficient organobase-catalyzed method for the synthesis of fully decorated chiral 4-acyl-5-aryl-trisubstituted-1,2,3-triazole-linked -glycosidic molecular scaffolds as glycohybrids. This process involves a base-catalyzed 1,3 dipolar cycloaddition reaction,...
4.
Ansari M, Kulkarni Y, Singh K
Pharm Dev Technol
. 2025 Feb;
:1-13.
PMID: 39985152
The existing study focuses on the development, optimization, and evaluation of sorafenib-loaded polymeric nanomicelles for posterior segment delivery in treating retinoblastoma. The formulation involved adjusting various process and product parameters...
5.
Pounds R, Croft W, Pearce H, Hossain T, Singh K, Balega J, et al.
Front Immunol
. 2025 Jan;
15():1477781.
PMID: 39835114
Introduction: Ovarian cancer (OC) is the sixth most common malignancy in women and the poor 5-year survival emphasises the need for novel therapies. NK cells play an important role in...
6.
Ansari M, Gupta C, Kulkarni Y, Singh K
Int J Pharm
. 2025 Jan;
671:125235.
PMID: 39826786
The current research discusses polymer conjugation, formulation development, and evaluation of sorafenib-loaded polymeric nanomicelles of conjugated soluplus (solu-tin) and polymeric mixed nanomicelles of conjugated soluplus (solu-tin) with conjugated poloxamer 188...
7.
Verma K, Garg T, Singh S, Deivreddy V, Raman S, Bharti R, et al.
Tuberculosis (Edinb)
. 2025 Jan;
151:102606.
PMID: 39823776
The limitations of existing mouse models of lung infection with Mycobacteroides abscessus impede drug discovery and development. In contrast to current animal models that introduce NTM intravenously or by intranasal/intra-tracheal...
8.
Reuter A, Ali M, Mohan V, Chwastiak L, Singh K, Narayan K, et al.
NPJ Digit Med
. 2024 Dec;
7(1):357.
PMID: 39658561
A substantial share of patients at risk of developing cardiovascular disease (CVD) fail to achieve control of CVD risk factors, but clinicians lack a structured approach to identify these patients....
9.
Kiru G, Roy A, Kondal D, Chandrasekaran A, Mukherjee S, Mohan B, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2024 Nov;
23:200346.
PMID: 39554875
Background: The burden of over 300 million individuals living with hypertension in India is increasing steadily. Most current guidelines recommend initial combination therapy for effective blood pressure (BP) control. However,...
10.
Singh K, Kondal D, Mohan D, Gandral M, Rajan S, Mohan V, et al.
Indian Heart J
. 2024 Nov;
76(6):376-384.
PMID: 39547572
Background: Assessment of knowledge, attitudes, and practices regarding cardiovascular diseases (CVD) and cardiovascular risk factors (CVRF) is critical to inform CVD prevention strategies, but limited community-level data exist from developing...